Edge Wealth Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Edge Wealth Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-840	Closed	-$52K	–	590
2018 Q4	$52K	Hold	840	–	–	0.01%	244
2018 Q3	$62K	Hold	840	–	–	0.01%	236
2018 Q2	$56K	Hold	840	–	–	0.01%	236
2018 Q1	$52K	Sell	840 -110	-12%	-$7.24K	0.01%	220
2017 Q4	$61K	Hold	950	–	–	0.02%	206
2017 Q3	$62K	Hold	950	–	–	0.02%	206
2017 Q2	$60K	Hold	950	–	–	0.02%	210
2017 Q1	$56K	Buy	950 +110	+13%	+$6.43K	0.02%	203
2016 Q4	$47K	Sell	840 -972	-54%	-$56K	0.02%	196
2016 Q3	$112K	Sell	1,812 -336	-16%	-$22K	0.05%	135
2016 Q2	$136K	Buy	2,148 +1,130	+111%	+$71.1K	0.06%	122
2016 Q1	$61K	Buy	+1,018	New	+$62.3K	0.03%	161

Other funds holding PJP

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Edge Wealth Management's PJP Position: Q1 2019 in Review

Edge Wealth Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2019, closing a stake of 840 shares — an estimated $52K sold.

Edge Wealth Management first reported a position in PJP in Q1 2016 and held it in 12 quarters. The position peaked at $136K in Q2 2016. 95 funds tracked by Wall St. Rank hold PJP as of Q1 2019.

Edge Wealth Management reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2019 after selling out during the quarter.
Edge Wealth Management sold 840 Invesco Pharmaceuticals ETF shares in Q1 2019, an estimated $52K.
Edge Wealth Management first reported a position in Invesco Pharmaceuticals ETF in Q1 2016 and held it in 12 quarters.
Edge Wealth Management's Invesco Pharmaceuticals ETF position peaked at $136K in Q2 2016.
95 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2019.

Based on Edge Wealth Management's 13F filing for Q1 2019, filed 11 Apr 2019.